CPMV (Mosaic ImmunoEngineering) Total Liabilities: $7.66 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mosaic ImmunoEngineering Total Liabilities?

Mosaic ImmunoEngineering CPMV +11.11% Total Liabilities is $7.66 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Mosaic ImmunoEngineering's Total Liabilities for the quarter that ended in Mar. 2026 was $7.66 Mil.

Mosaic ImmunoEngineering's quarterly Total Liabilities increased from Sep. 2025 ($7.36 Mil) to Dec. 2025 ($7.50 Mil) and increased from Dec. 2025 ($7.50 Mil) to Mar. 2026 ($7.66 Mil).

Mosaic ImmunoEngineering's annual Total Liabilities increased from Dec. 2023 ($6.05 Mil) to Dec. 2024 ($6.93 Mil) and increased from Dec. 2024 ($6.93 Mil) to Dec. 2025 ($7.50 Mil).


Mosaic ImmunoEngineering Total Liabilities Historical Data

* Premium members only.

The historical data trend for Mosaic ImmunoEngineering's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mosaic ImmunoEngineering Total Liabilities Chart

Mosaic ImmunoEngineering Annual Data
Trend May16 May17 May18 May19 May20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.07 5.15 6.05 6.93 7.50

Mosaic ImmunoEngineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.07 7.20 7.36 7.50 7.66

Mosaic ImmunoEngineering Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mosaic ImmunoEngineering's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.03+(1.466+2.2204460492503E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=7.50

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=0.02--7.476
=7.50

Mosaic ImmunoEngineering's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=0.01--7.651
=7.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $7.66 Mil mean?
Mosaic ImmunoEngineering (CPMV) has a Total Liabilities of $7.66 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Mosaic ImmunoEngineering and its competitors.
Is Mosaic ImmunoEngineering's Total Liabilities too high?
Mosaic ImmunoEngineering's current Total Liabilities is $7.66 Mil.
How does Mosaic ImmunoEngineering's Total Liabilities compare to TCRT and JAGX?
Mosaic ImmunoEngineering's Total Liabilities of $7.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Mosaic ImmunoEngineering and its competitors. Mosaic ImmunoEngineering's current Total Liabilities is $7.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mosaic ImmunoEngineering stock overvalued right now?
Mosaic ImmunoEngineering (CPMV) has a current Total Liabilities of $7.66 Mil. The current Total Liabilities is $7.66 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Mosaic ImmunoEngineering (CPMV), the current Total Liabilities is $7.66 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mosaic ImmunoEngineering Business Description

Address 9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646
Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions. The company is pursuing new product candidates and platforms to build a product pipeline based on its deep understanding of immunotherapies.